Skip to main content

Table 3 Rates of decline in eGFR per year

From: Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study

  Mean ± SD P value Trend P
eGFR  
 Stage G3a −1.925 ± 5.681 0.003 0.003
 Stage G3b −2.056 ± 5.924
 Stage G4 −3.182 ± 14.189
 Stage G5 −3.754 ± 6.374
Hypertension  
 Group 1 −3.480 ± 6.650 0.154  
 Group 2 −2.641 ± 10.440
UACR (mg/g Cre)
 <300 −0.546 ± 4.690 <0.0001 <0.0001
 300–999 −2.399 ± 6.297
 ≥1000  −4.560 ± 4.894
  1. Values are expressed as mean ± SD
  2. Stage G3a, eGFR: 45–59 mL/min/1.73 m2; stage G3b, eGFR: 30–44 mL/min/1.73 m2; stage G4, eGFR: 15–29 mL/min/1.73 m2; stage G5, eGFR: <15 mL/min/1.73 m2; Group 1, ≥140 mmHg in SBP and/or ≥90 mmHg in DBP; Group 2, <140 mmHg in SBP and <90 mmHg in DBP
  3. eGFR estimated glomerular filtration rate, UACR urine albumin-to-creatinine ratio, Cre creatinine, DBP diastolic blood pressure, SBP systolic blood pressure